Mayo Clinic Laboratory and Pathology Research Roundup: Feb. 12 - Insights
This week’s Research Roundup highlights the prediction of oncologic outcomes in Renal cell carcinoma after surgery.
Research Roundup Archives - Page 11 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Page 12 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Archives - Page 29 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Archives - Page 28 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
Plummer Building #ThrowbackThursday - Insights
Opened in 1928, the Plummer Building is an iconic symbol of Mayo Clinic, designated as a National Historic Landmark. It is named for Henry S. Plummer, M.D., the “diversified genius” who designed it and who created many of the systems and...
In an article about "titans who defined a new era in business during the last decade," former Mayo Clinic President and CEO John Noseworthy, M.D., looked back on his tenure with gratitude.
Mayo Clinic Laboratory and pathology research roundup: January 17 - Insights
This week's research roundup features: Exploring gene expression profiles in primary central nervous system vasculitis
Research Archives - Page 8 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Page 9 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Page 8 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Page 10 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Page 24 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Page 23 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Week in Review: April 22 - Insights
Today's highlights include: Study mines cancer genetics to help with targeted treatment, Mayo Clinic to launch staffing tool app to find 'right nurse for the right role', and new blood biomarker may lead to early diagnosis of frontotemporal...
Week in Review: May 6 - Insights
Today's highlights include: Mental health needs rise as pandemic fluctuates, an algorithm that analyzes apple watch data shows early promise in detecting heart problems, and Minnesota physicians brace for Roe v. Wade decision
Mayo Clinic Laboratory and Pathology Research Roundup: March 11 - Insights
This week’s Research Roundup highlights an assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients and several other research articles by Mayo Clinic physicians...
Jessica Wright, Pharm.D., BCACP, explains how Mayo Clinic Laboratories' 3A5Q test helps determine initial tacrolimus doses for individuals after non-liver organ transplants. Optimal tacrolimus levels are one of the important factors in...
New tests launched in November - Insights
In November 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Novel panel identifies toxins linked to asthma and GI diseases - Insights
Melissa Snyder, Ph.D., explains how Mayo Clinic Laboratories' EDN panel improves the evaluation of certain patients with asthma and autoimmune digestive disorders. EDN is the first laboratory test that provides a marker of...
Updated testing algorithms for plasma cell proliferative disorders [Test in Focus] - Insights
Xinjie Xu, Ph.D., co-director of Mayo's Genetics and Genomics Laboratory, explains Mayo Clinic Laboratories' updated approach to testing for risk stratification of patients newly diagnosed with plasma cell proliferative disorders, such as...
Neurofascin 155 IgG4 Antibody Test [Test in Focus] - Insights
John Mills, Ph.D., explains Mayo Clinic Laboratories' new neurofascin 155 (NF155) IgG4 antibody test, which is the first commercially available test in the U.S. to use flow cytometry to detect for NF155 antibodies and confirm diagnosis of...
Bobbi Pritt, M.D., Comments on Blacklegged Ticks in Minnesota Conservation Volunteer - Insights
Blacklegged ticks (also known as deer ticks) are turning up more frequently in Minnesota, and so are the diseases they carry. Bobbi Pritt, a parasitologist in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester,...
New Year's Specimen Shipping Guidelines and Schedule - Insights
Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered for the New Year's holiday. To ensure specimen viability and minimize delays, the following adjustments and guidelines have been implemented and will be...
Testing Archives - Page 25 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
New Tests Launched Archives - Page 5 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
New Tests Launched Archives - Insights
Skip to Content MayoACCESS MayoLINK...
New Tests Launched Archives - Page 2 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
New Tests Launched Archives - Page 3 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
New Tests Launched Archives - Page 4 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 13 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Five steps for successful outreach program implementation - Insights
Learn the five elements essential to successfully implementing a complex outreach program project and what is at risk if you miss an element.
Practical Approaches to Outreach Marketing - Insights
Marketing is an essential discipline of any successful laboratory outreach program. While specific marketing goals and audiences will differ for every program, most of them will certainly involve driving awareness and growth. A strong...
Managing Operational Surprises in Real Time - Insights
While preparation is key to mitigating risk, inevitably, there are unforeseen circumstances that will impact operations. Here are four ways the outreach laboratory can swiftly manage operational surprises in real time.
The Expanding Reach of the Laboratory Outreach Program - Insights
The most successful laboratory outreach programs recognize the importance of serving multiple customers. From provider to patient to healthcare consumer, the laboratory has an opportunity to serve them all with high-quality results and...
Matthew J. Schultz, Ph.D., and Amy L. White, M.S., CGC, explain how Mayo Clinic Laboratories' unique urine assay (Mayo ID: SORD) screens for peripheral neuropathy arising from SORD gene variants. Although recently identified, SORD-related...
Disaccharidase Activity Panel [Test in Focus] - Insights
Pua Hopson, D.O., discusses Mayo Clinic Labs’ new disaccharidase activity panel, which measures levels of five digestive enzymes to identify deficiencies that cause carbohydrate maldigestion and can lead to chronic conditions like celiac...
Alicia Algeciras-Schimnich, Ph.D., discusses Mayo Clinic Laboratories’ new noninvasive plasma biomarker assay for Alzheimer’s disease, an accessible, highly accurate testing option for individuals age 50 and above who are experiencing mild...
Updated assay guides diagnosis of autoimmune liver disease: Anne Tebo, Ph.D. - Insights
Anne Tebo, Ph.D., explains how Mayo Clinic Laboratories' updated ALDG2 assay helps with the evaluation of patients with suspected autoimmune liver disease. The panel also helps with the evaluation of liver disease of unknown etiology.
Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D. - Insights
David S. Viswanatha, M.D., explains how Mayo Clinic Laboratories' new assay provides rapid, definitive diagnosis of VEXAS, a recently identified syndrome affecting older men. Early diagnosis is key to managing the syndrome, which severely...
Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D. - Insights
Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' unique genetic tests identify patients at high risk of severe reactions to fluoropyrimidines — a type of chemotherapy drug. Test results can guide clinical decision-making for...
Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D. - Insights
Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost...
What's New in Health Care Reform: Jan. 23 - Insights
Top highlights include: Physician burnout now essentially a public health crisis, Americans more likely to die from opioid overdose than in a car accident, study identifies biomarkers to stratify patients for prostate cancer treatment, the...
Learn how Mayo Clinic Laboratories and hospitals we work with around the world balance strong financial performance and world-class patient care.
December 2023 - Gastroenterology Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Gastroenterology Pathology.
November 2023 - Cardiovascular Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Cardiovascular Pathology.
July 2023 - Breast Pathology Case 2 - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Breast Pathology.
March 2021 — Cardiovascular Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Cardiovascular Pathology.
October 2023 - Pulmonary Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Pulmonary Pathology.
April 2023 - Clinical Chemistry - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Chemistry.